10-K

Company

Mereo BioPharma Group plc

Filed

March 26, 2025

Period of Report

December 31, 2024

Accession Number

0000950170-25-044787

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →